Radiosensitization by an anti-EGFR single chain antibody in human head and neck cancer cells

被引：0
|
作者：
Bonner, J. [1 ]
Trummell, H. Q. [1 ]
Sanford, L. L. [1 ]
Raisch, K. P. [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2007年 / 82卷
关键词：
D O I：
10.1016/S0167-8140(07)80098-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
98
引用
收藏
页码：S32 / S33
页数：2
相关论文
共 50 条
  • [41] h-R3. Treatment of head and neck cancer - Treatment of epithelial tumors anti-EGFR MAb
    Ramos, TC
    Parada, AC
    Escobar, NI
    DRUGS OF THE FUTURE, 2003, 28 (09) : 847 - 853
  • [42] ANTI-EGFR ANTIBODY RECHALLENGE IN CHEMOREFRACTORY PATIENTS WITH METASTATIC COLORECTAL CANCER
    Kajitani, Tatsuhiro
    Makiyama, Akitaka
    Arita, Shuji
    Kumagai, Hozumi
    Oda, Hisanobu
    Shirakawa, Tsuyoshi
    Esaki, Taito
    ANNALS OF ONCOLOGY, 2014, 25
  • [43] Anti-EGFR monoclonal antibody in cancer treatment: in vitro and in vivo evidence
    Quatrale, Anna Elisa
    Petriella, Daniela
    Porcelli, Letizia
    Tommasi, Stefania
    Silvestris, Nicola
    Colucci, Giuseppe
    Paradiso, Angelo
    Azzariti, Amalia
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 1973 - 1985
  • [44] Concurrent chemoradiation (CCRT) or radiotherapy (RT) with anti-EGFR directed monocolonal antibody (antiEGFR) or CCRT plus anti-EGFR in locoregionally advanced squamous cell carcinoma of the head and neck LA-HNSCC)
    Janssens, Katleen
    Vermorken, Jan B.
    Specenier, Pol
    ACTA CLINICA BELGICA, 2016, 71 : 18 - 18
  • [45] Cetuximab. Anti-EGFR monoclonal antibody
    Etessami, A
    Bourhis, J
    DRUGS OF THE FUTURE, 2000, 25 (09) : 895 - 899
  • [46] A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
    Machiels, J. -P.
    Specenier, P.
    Krauss, J.
    Dietz, A.
    Kaminsky, M. -C.
    Lalami, Y.
    Henke, M.
    Keilholz, U.
    Knecht, R.
    Skartved, N. J.
    Horak, I. D.
    Pamperin, P.
    Braun, S.
    Gauler, T. C.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 13 - 20
  • [47] A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
    J.-P. Machiels
    P. Specenier
    J. Krauß
    A. Dietz
    M.-C. Kaminsky
    Y. Lalami
    M. Henke
    U. Keilholz
    R. Knecht
    N. J. Skartved
    I. D. Horak
    P. Pamperin
    S. Braun
    T. C. Gauler
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 13 - 20
  • [48] AllergoOncology: cetuximab-like anti-EGFR IgE antibody facilitates the interaction of mast cells with EGFR plus human hepatocarcinoma cells
    Rohr-Udilova, N.
    Matz, M.
    Salzmann, M.
    Seif, M.
    Pinter, M.
    Trauner, M.
    Karagiannis, S. N.
    Jensen-Jarolim, E.
    Bianchini, R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 74 - 75
  • [49] MM-151 Oligoclonal anti-EGFR antibody combination Treatment of colorectal cancer Treatment of non-small cell lung cancer Treatment of head and neck cancer
    Haddley, K.
    DRUGS OF THE FUTURE, 2016, 41 (12) : 725 - 730
  • [50] Synergy of anti-EGFR antibody combination leading to superior anti-cancer efficacy
    Pedersen, Mikkel
    Jacobsen, Helle
    Pyke, Charles
    Hey, Adam
    Kragh, Michael
    Haurum, John
    CANCER RESEARCH, 2009, 69
12345